Myofascial Induction in Breast Cancer Survivors

October 13, 2021 updated by: Manuel Arroyo Morales, Universidad de Granada

Randomized, Single-blind, Placebo-controlled Cross-over Design of Myofascial Induction and Placebo Electrotherapy in Breast Cancer Survivors

The purpose of this study was to show the immediate effects of myofascial induction on perceived pain and anxiety, cervical/shoulder range of motion and mood state in breast cancer survivors suffering shoulder/arm morbidity.

Study Overview

Detailed Description

Background: To investigate the immediate effects of myofascial induction on perceived pain and anxiety, cervical/shoulder range of motion and mood state in breast cancer survivors suffering shoulder/arm morbidity.

Methods: Randomized, single-blind, placebo-controlled cross-over study. Twenty-one enrolled participants who had a diagnosis of breast cancer stage I-IIIA and had completed adjuvant therapy except hormonal treatment. The study consisted of two intervention sessions of 30 minutes separated by a wash-up period of 4 weeks. The interventions consisted of a Myofascial Induction (experimental group) or placebo pulsed shortwave therapy (control group). The main outcome measures were: Visual Analogue Scale for pain and anxiety, shoulder-cervical goniometry for range of motion, Profile of Mood States for psychological distress and Attitudes Toward Massage Scale.

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Granada, Spain, 18016
        • Faculty of health Sciences. University of Granada

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

23 years to 63 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • had a diagnosis of breast cancer (cancer stage I-IIIA)
  • was between the ages of 25 and 65
  • had completed adjuvant therapy except hormonal treatment

Exclusion Criteria:

  • had cancer recurrence

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Myofascial Induction session
Patients received a Myofascial Induction focused on the upper limb area for 30 minutes using the Pilat approach.
Patients received a Myofascial Induction focused on the upper limb area for 30 minutes using the Pilat approach.
Placebo Comparator: Placebo session
Patients received a placebo session consisted of 30 minutes of unplugged pulsed shortwave therapy.
Patients received a placebo session consisted of 30 minutes of unplugged pulsed shortwave therapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS). Change scores
Time Frame: A wash-up period of 4 weeks between the 2 sessions was established
A numerical rating scale that contains scores in the range of 0 to 10 (0 = 'no pain/anxiety'; 10 = 'worst imaginable pain/anxiety level'). Participants must mark the level of pain that they feel at that moment in the cervical-arm area and use the scale to indicate their anxiety level.
A wash-up period of 4 weeks between the 2 sessions was established

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Goniometry shoulder. Change scores
Time Frame: A wash-up period of 4 weeks between the 2 sessions was established
A plastic universal goniometer with two adjustable overlapping arms to measure the active range of motion of the shoulder joint.
A wash-up period of 4 weeks between the 2 sessions was established
Goniometry cervical. Change scores
Time Frame: A wash-up period of 4 weeks between the 2 sessions was established
A cervical goniometric device manufactured by Performance Attainment Associates (St Paul, MN, USA) to measure the active range of motion of the cervical joints.
A wash-up period of 4 weeks between the 2 sessions was established
Profile of Mood States (POMS). Change scores
Time Frame: A wash-up period of 4 weeks between the 2 sessions was established
This questionnaire is a measure of psychological distress. This questionnaire contains 65 items assessing mood state, which are grouped into six subscales: tension-anxiety, depression-dejection, anger-hostility, vigour-activity, fatigue-inertia and confusion-bewilderment.
A wash-up period of 4 weeks between the 2 sessions was established
Attitudes toward massage (ATOM) scale
Time Frame: Covariates
The Attitudes toward massage (ATOM) scale is a nine-item measure of overall attitude toward massage composed of the 'Massage as Healthful' and the 'Massage as Pleasant' subscales.
Covariates

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Manuel Arroyo-Morales, PhD, Deparment of Physical Therapy, Faculty of Health Sciences, University of Granada

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2014

Primary Completion (Actual)

August 1, 2017

Study Completion (Actual)

October 1, 2017

Study Registration Dates

First Submitted

August 1, 2016

First Submitted That Met QC Criteria

August 3, 2016

First Posted (Estimate)

August 8, 2016

Study Record Updates

Last Update Posted (Actual)

October 18, 2021

Last Update Submitted That Met QC Criteria

October 13, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • FIS PI10/02749-02764

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Myofascial Induction

3
Subscribe